Empower your mind to embrace your… for Parkinson's (NCT07310147)
Reduce anxiety and improve functioning
- Trial ID
- NCT07310147
- Official Title
- Empower Your Mind to Embrace Your Life: Development and Efficacy Study of a Videoconference-delivered Group Intervention Based on Acceptance and Commitment Therapy for People With Young-onset Parkinson's Disease
- Goal
- Reduce anxiety and improve functioning
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- University of Coimbra
- Study Type
- INTERVENTIONAL
- Enrollment
- 20 participants
- Conditions
- Parkinson's Disease (PD)
- Interventions
- Empower your mind to embrace your life
Summary For Families
Aiming to help people with young-onset Parkinson's manage distress, anxiety, and loss of everyday functioning by increasing psychological flexibility and overall quality of life. It offers a group Acceptance and Commitment Therapy program delivered by videoconference, teaching acceptance of difficult thoughts and sensations, mindfulness, and committed, values-driven action; as a talk-based therapy it complements usual Parkinson's medications like levodopa and does not change how those drugs work. Looking for Portuguese-speaking adults 21 to 65 years old with neurologist-confirmed young-onset PD in Hoehn and Yahr stages 1 to 2.5, and excludes those currently in psychological treatment, pregnant people, anyone with current suicidal ideation, severe psychiatric illness, or cognitive impairment.
Locations
- CINEICC, Coimbra, Portugal
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Empower your mind to embrace your life. Aiming to help people with young-onset Parkinson's manage distress, anxiety, and loss of everyday functioning by increasing psychological flexibility and overall quality of life. It offers a group Acceptance and Commitment Therapy program delivered by videoconference, teaching acceptance of difficult thoughts and sensations, mindfulness, and committed, values-driven action; as a talk-based therapy it complements usual Parkinson's medications like levodopa and does not change how those drugs work. Looking for Portuguese-speaking adults 21 to 65 years old with neurologist-confirmed young-onset PD in Hoehn and Yahr stages 1 to 2.5, and excludes those currently in psychological treatment, pregnant people, anyone with current suicidal ideation, severe psychiatric illness, or cognitive impairment.
- Who can participate?
- Participants must be between 21 Years and 65 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 3 months.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- This trial has a group that receives no study treatment (you would continue your usual care) alongside the treatment group. Because assignment is random, you have about a 1 in 2 chance (roughly 50%) of being in the no-treatment group, assuming the groups are filled equally. Ask the coordinator to confirm the exact assignment ratio.
- How many visits does this trial involve?
- The study includes eight weekly online sessions and outcome assessments at pre-intervention, post-intervention, and at 3-month follow-up.